Stocks / Stock overview

Morgan Stanley (MS)

$214.77-0.04%Aft $214.50 (-0.13%)Market cap $337.31B

NYSE · Price as of · Delayed Quote

Stock Scorer
Scoring…
Analyst consensus
Rated$236.62
  • Analysts21
  • Implied upside+10.2%
  • Target range$184.00 to $262.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
October 14, 2026before the open
  • EPS expected$3.16 +13%
  • A year ago$2.80
  • Revenue expected$20.84B +14%
  • Estimate range$2.90 to $3.56
Consensus of 14 analysts for the quarter ending September 30, 2026. Beat the estimate in all four of the last four quarters. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar

How Congress has done in MS

Source: AIStockWire, scored from STOCK Act disclosures against daily price historyGenerated

Every purchase of MS disclosed by a member of Congress in the last 5 years, scored over the 12 months after the trade date against SPY over the same window.

MeasureMSSPY
Median 12-month return after purchase+18.7%+27.0%
Median difference vs SPY-6.0%
Purchases that beat SPY4 of 9 (44%)
Members who bought6

Most frequent buyers: Michael Guest (3), Marjorie Taylor Greene (2), Greg Stanton (1), Josh Gottheimer (1), Ritchie Torres (1).

These are not returns anyone actually earned. Disclosures report a dollar bracket and no share count, so every purchase is counted once and weighted equally, and sales are not matched back to the buys that opened them. 4 of the 9 purchases are disclosed as a spouse's or dependent's rather than the member's own. Purchases from the last 12 months are excluded because their window has not closed yet.

Congress trades

Source: STOCK Act disclosures filed with the House and SenateLatest disclosed

DateMemberActionAmount
2026-07-10Dan Newhouse WAPurchase$1,001 - $15,000
All congress trades

SEC filings

Source: SEC EDGARLatest filed

FormFiledDescription
424B2August 28, 2026PRICING SUPPLEMENT NO. 17,887
424B2August 28, 2026PRICING SUPPLEMENT NO. 18,083
424B2August 28, 2026PRICING SUPPLEMENT NO. 18,046
424B2August 28, 2026PRICING SUPPLEMENT NO. 17,948
424B2August 28, 2026PRICING SUPPLEMENT NO. 17,849
424B2August 28, 2026PRICING SUPPLEMENT NO. 17,645
424B2August 28, 2026PRICING SUPPLEMENT NO. 17,946
424B2August 28, 2026PRELIMINARY PRICING SUPPLEMENT NO. 18,440
All SEC filings

Frequently asked questions

When does MS report earnings?

Morgan Stanley (MS) is scheduled to report quarterly results on October 14, 2026, before the open. The 14-analyst consensus is $3.16 per share on revenue of $20.84B for the quarter ending September 30, 2026, against $2.80 and $18.22B a year earlier. It has beaten the consensus EPS estimate in all four of the last four quarters.

What do analysts expect for MS?

21 analysts cover Morgan Stanley (MS). No consensus rating has been published. The average price target is $236.62, in a range of $184.00 to $262.00.

Are insiders buying or selling MS?

We have no qualifying Form 4 insider purchases or sales on record for Morgan Stanley (MS). Sales are only tracked above a dollar threshold, so small routine trades may not appear.

Has Congress made money trading MS?

6 members of Congress have disclosed buying MS in the last 5 years, 9 purchases in total. Measured over the 12 months after each trade date, the median purchase returned +18.7% against +27.0% for SPY over the same windows, and 4 of the 9 (44%) beat the index. These are not returns anyone actually earned: congressional disclosures report a dollar bracket and no share count, so each purchase is counted once and weighted equally, and later sales are not matched back to the buys that opened them.

Where can I see MS SEC filings?

Recent filings are listed on this page, newest first. The latest is a 424B2 filed August 28, 2026.

Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.